Zoetis K9 Para (4/5/2022)
From Line
Clinician’s Brief Partner Webinars
CB Partner Webinar
1 hour
Zoetis
{{webinarsautomatedemailsregistrationconfirmation::client_only_logo}}
{{webinarsautomatedemailsregistrationconfirmation::client_only_logo_self_hosted}}
{{webinarsautomatedemailsregistrationconfirmation::client_only_logo_alt}}
{{webinarsautomatedemailsregistrationconfirmation::client_only_logo_width}}
{{webinarsautomatedemailsregistrationconfirmation::client_only_logo_custom_css}}
{{webinarsautomatedemailsregistrationconfirmation::client_color}}
{{webinarsautomatedemailsregistrationconfirmation::supported_by}}
Areas of the country that have not historically reported heartworm cases are now recognizing increased case numbers, and they are higher in endemic areas, despite the broad availability of heartworm preventives for decades. In addition to the increasing prevalence, there is also the issue of macrocyclic lactone-resistant heartworms, all of which will be explored in this presentation.
An introduction to macrocyclic lactones
The difference among lack of efficacy claims, poor compliance, and drug resistance
Current updates on drug resistance in heartworm disease
The areas of drug resistance in the US
What you need to know for your patients
{{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_6}}
Thank you for registering for "#EVENTTITLE#," sponsored by Zoetis.
Thank you for registering for "#EVENTTITLE#."
|
|
Dear #FIRSTNAME#,
|
Thank you for registering for "#EVENTTITLE#," sponsored by Zoetis.
Thank you for registering for "#EVENTTITLE#."
|
Areas of the country that have not historically reported heartworm cases are now recognizing increased case numbers, and they are higher in endemic areas, despite the broad availability of heartworm preventives for decades. In addition to the increasing prevalence, there is also the issue of macrocyclic lactone-resistant heartworms, all of which will be explored in this presentation.
|
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
|
|
Learning Objectives
|
- An introduction to macrocyclic lactones
- The difference among lack of efficacy claims, poor compliance, and drug resistance
- Current updates on drug resistance in heartworm disease
- The areas of drug resistance in the US
- What you need to know for your patients
|
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
|
|
Webinar Details
|
#EVENTDAY#, #EVENTDATE# | #EVENTTIME# #EVENTTIMEZONESHORT# | 1 hour
|
Sponsored by Zoetis
|
|
Add to Your Calendar
|
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
|
#CALENDARREMINDER#
|
|
How to Join the Webinar
|
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
|
#AUDIENCEURL#
|
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
|
|
Thank you for registering! We look forward to seeing you.
|
Sincerely,
|
The Clinician's Brief Team
|
The Zoetis Team
|
|
|
|
</head>
<body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Thank you for registering for "#EVENTTITLE#," sponsored by Zoetis.
Thank you for registering for "#EVENTTITLE#."
|
|
Dear #FIRSTNAME#,
|
Thank you for registering for "#EVENTTITLE#," sponsored by Zoetis.
Thank you for registering for "#EVENTTITLE#."
|
Areas of the country that have not historically reported heartworm cases are now recognizing increased case numbers, and they are higher in endemic areas, despite the broad availability of heartworm preventives for decades. In addition to the increasing prevalence, there is also the issue of macrocyclic lactone-resistant heartworms, all of which will be explored in this presentation.
|
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
|
|
Learning Objectives
|
- An introduction to macrocyclic lactones
- The difference among lack of efficacy claims, poor compliance, and drug resistance
- Current updates on drug resistance in heartworm disease
- The areas of drug resistance in the US
- What you need to know for your patients
|
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
|
|
Webinar Details
|
#EVENTDAY#, #EVENTDATE# | #EVENTTIME# #EVENTTIMEZONESHORT# | 1 hour
|
Sponsored by Zoetis
|
|
Add to Your Calendar
|
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
|
#CALENDARREMINDER#
|
|
How to Join the Webinar
|
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
|
#AUDIENCEURL#
|
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
|
|
Thank you for registering! We look forward to seeing you.
|
Sincerely,
|
The Clinician's Brief Team
|
The Zoetis Team
|
|
|
|